These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12176529)

  • 1. Acute rejection after renal transplantation with tacrolimus-based therapy in conditions of normal clinical practice.
    Scolari MP; Citterio F; Baldan N; Rigotti P; Castagneto M; Stefoni S; Segoloni G
    Transplant Proc; 2002 Aug; 34(5):1671-2. PubMed ID: 12176529
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus monotherapy in renal transplantation: four-year data.
    Coupes BM; Speake M; Johnson RW; Roberts IS; Campbell B; Short CD
    Transplant Proc; 2002 Aug; 34(5):1612-3. PubMed ID: 12176506
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of tacrolimus and neoral-based immunosuppressive regimens in renal transplantation patients: singles-center experience.
    Gurkan A; Tuncer M; Colak T; Erdoğan O; Demirbas A; Dosemeci L; Yakupoglu G
    Transplant Proc; 2002 Aug; 34(5):1661-2. PubMed ID: 12176525
    [No Abstract]   [Full Text] [Related]  

  • 4. One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation.
    Campos HH; Abbud Filho M;
    Transplant Proc; 2002 Aug; 34(5):1656-8. PubMed ID: 12176523
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary immunosuppression with tacrolimus in renal transplantation: a single center experience.
    Kim HC; Park SB; Han SY; Whang EA; Jeon DS; Kim HT; Cho WH; Park CH
    Transplant Proc; 2003 Feb; 35(1):217-8. PubMed ID: 12591370
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus for rescue therapy in refractory renal allograft rejection.
    Jang HJ; Kim SC; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1765-6. PubMed ID: 11119925
    [No Abstract]   [Full Text] [Related]  

  • 7. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
    Pascual J; Ortuño J;
    Transplant Proc; 2002 Feb; 34(1):89-91. PubMed ID: 11959198
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH
    Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
    Cronin DC; Bruce DS; Newell KA; Josephson MA; Millis JM; Piper JB; Ruebe M; Kirby M; Thistlethwaite JR; Woodle ES
    Transplant Proc; 1997; 29(1-2):307. PubMed ID: 9123010
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study.
    Park K; Ahn C; Bang BK; Kang CM; Kim SI; Kim SJ; Kim YS; Kim YS; Koh YB; Kwak JY; Kwon OJ; Moon IS; Moon JI;
    Transplant Proc; 2000 Nov; 32(7):1705-8. PubMed ID: 11119901
    [No Abstract]   [Full Text] [Related]  

  • 11. Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy.
    Wayman MR; Oniscu GC; Forsythe JL; Whitworth CE
    Transplant Proc; 2002 Aug; 34(5):1663-5. PubMed ID: 12176526
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus Multicenter Renal Study.
    Mayer AD
    Transplant Proc; 2002 Aug; 34(5):1491-2. PubMed ID: 12176452
    [No Abstract]   [Full Text] [Related]  

  • 13. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D
    Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection therapy with tacrolimus in renal transplantation: preliminary results of a collaborative multicenter study in 45 patients. Groupe Cooperatif de Transplantation D'ile de France (GCIF).
    Maroun T; Aubert P; Baron C; Bedrossian J; Fornairon S; Lang P; Pruna A; Hiesse C
    Transplant Proc; 1998 Sep; 30(6):2811-2. PubMed ID: 9745576
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months.
    Budde K; Fritsche L; Smettan S; Schönberger B; Loening SA; Mai I; Bauer S; Waiser J; Neumayer HH
    Transplant Proc; 1998 Jun; 30(4):1238-9. PubMed ID: 9636503
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
    Tojimbara T; Kimikawa M; Nakajima I; Sato S; Nakamura M; Ishida H; Tanabe K; Koyama I; Utsumi K; Sannomiya A; Tsuji K; Fuchinoue S; Agishi T
    Transplant Proc; 1999 Nov; 31(7):2763-4. PubMed ID: 10578282
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction versus non-induction protocols in anti-calcineurin-based immunosuppression.
    Charpentier B
    Transplant Proc; 2001; 33(7-8):3334-6. PubMed ID: 11750425
    [No Abstract]   [Full Text] [Related]  

  • 19. Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction.
    Garcia CD; Schneider L; Barros VR; Guimarães PC; Garcia VD
    Transplant Proc; 2002 Nov; 34(7):2533-4. PubMed ID: 12431513
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience.
    Urbizu JM; Amenabar JJ; Gomez-Ullate P; Zarraga S; Lampreabe I
    Transplant Proc; 2002 Feb; 34(1):87-8. PubMed ID: 11959197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.